1 Result(s)

Article

Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare

Beginning in July of 2018, the FDA issued a voluntary recall regarding the presence of a contaminant found in the manufacturing of valsartan. What would ensue has become a largely unprecedented sequence of ala...

Michael Gillette, Addison Taylor, Djenita Butulija… in Cardiovascular Drugs and Therapy (2020)